Now included in Lexi-Drugs:
Updated CHEST guidelines and Beers criteria!
Long considered the "bible" for the standard of care for physicians dealing with chest medicine, CHEST and its supplements are written to provide best practices in the treatment of a variety of conditions. The newest CHEST guidelines (2012-9th ed.) regarding the use of antithrombotics/anticoagulants can be found within Lexi-Drugs monographs, impacting key fields such as Use, Dose, Clinical Practice Guidelines, Pregnancy, Warnings and more.
With the aging baby-boomer market, more and more clinicians are treating an increasing number of older adults and need to stay current on treatment recommendations. For these adults, you can access information from the latest Beers criteria (2012 Update) from within approximately 185 drug monographs in Lexi-Drugs for medications to avoid or to use with caution. Key Beers criteria-related information may be found in our Medication Safety Issues, Warnings/Precautions and Geriatric Consideration fields.
Lexi-Drugs, our most comprehensive drug database, contains content that addresses all patient populations and covers all clinical specialties such as Pharmacy, Cardiology, Internal Medicine, Oncology, Anesthesiology and more. With this #1 independently ranked and "pharma-free" drug database, you have access to up-to-date, in-depth pharmacology information; saving you time in researching questions to tough clinical questions. Drug monographs in Lexi-Drugs contain up to 67 fields of information, including Adverse Events, Contraindications, Dosing, Pharmacodynamics, Special Alerts and more. Available on the broadest range of mobile devices and tablets, Lexi-Drugs can help you improve patient care and medication safety right at the point-of-care! Learn more.